| __timestamp | Madrigal Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 15746000 | 675200000 |
| Thursday, January 1, 2015 | 13392000 | 771800000 |
| Friday, January 1, 2016 | 9290000 | 1205500000 |
| Sunday, January 1, 2017 | 7672000 | 1146500000 |
| Monday, January 1, 2018 | 15293000 | 1125800000 |
| Tuesday, January 1, 2019 | 22648000 | 1166100000 |
| Wednesday, January 1, 2020 | 21864000 | 1175500000 |
| Friday, January 1, 2021 | 37318000 | 1111400000 |
| Saturday, January 1, 2022 | 48130000 | 1210100000 |
| Sunday, January 1, 2023 | 108146000 | 1274600000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Madrigal Pharmaceuticals, Inc. and Perrigo Company plc have taken different paths in optimizing these costs.
From 2014 to 2023, Madrigal Pharmaceuticals saw a significant increase in SG&A expenses, rising from approximately $15.7 million to over $108 million. This represents a staggering 587% increase, reflecting their aggressive expansion and investment in administrative capabilities. In contrast, Perrigo Company plc maintained a more stable SG&A expenditure, with a modest increase of about 89% from $675 million to $1.27 billion over the same period.
While Madrigal's strategy indicates a focus on growth, Perrigo's steady approach suggests a commitment to efficiency. Understanding these trends provides valuable insights into each company's strategic priorities and operational efficiencies.
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Madrigal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Perrigo Company plc or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Vericel Corporation
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Mesoblast Limited